Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins.
G Assmann, … , A Capurso, K Oette
G Assmann, … , A Capurso, K Oette
Published March 1, 1977
Citation Information: J Clin Invest. 1977;59(3):565-575. https://doi.org/10.1172/JCI108672.
View: Text | PDF
Research Article

The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins.

  • Text
  • PDF
Abstract

In this study we have determined by radioimmunoassay and double immunoelectrophoresis the total quantities and distributions of A apoproteins in three adult patients affected with Tangier disease (hereditary alpha-lipoprotein deficiency). Compared with normal plasma, the total quantities of apoproteins A-I and A-II in Tangier plasma were determined to be less than 1% and 5-7%, respectively. In Tangier patients, approximately 90% of the apoprotein A-I sedimented when ultracentrifugations of plasma were carried out at density 1.21 g/ml KBr. By contrast, more than 95% of the apoprotein A-II floated under those conditions. In normal plasma, approximately 90% of both apoproteins A-I and A-II is found in the 1.063-1.21-g/ml KBr density fraction. These findings suggest that complete dissociation of A apoproteins occurs in Tangier plasma. This dissociation of apoproteins was confirmed by double immunoelectrophoresis with monospecific antisera. Immunochemical and electrophoretic experiments did not provide evidence for a structural abnormality of apoprotein A-I in these patients, The results taken together strongly suggest that normal high-density lipoproteins are absent from Tangier plasma.

Authors

G Assmann, E Smootz, K Adler, A Capurso, K Oette

×

Total citations by year

Year: 2018 2013 2011 2010 2006 2005 2003 2001 2000 1999 1998 1997 1996 1995 1993 1991 1990 1988 1987 1986 1985 1984 1983 1982 1981 1980 1979 1978 1977 1965 Total
Citations: 1 1 1 1 1 1 1 1 1 1 2 1 2 1 2 3 2 4 1 5 8 4 4 8 2 10 5 12 2 1 89
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (89)

Title and authors Publication Year
Finding a very rare mutation in non-Caucasian LCAT patients from Southwest Asia for the first time: OLIAEI et al
F Oliaei, B Batebi, R Tabaripour, HA Niaki
Journal of Cellular Biochemistry 2018
Vigna unguiculata modulates cholesterol induced cardiac markers, genotoxicity and gene expressions profile in an experimental rabbit model
PA Janeesh, A Abraham
Food & Function 2013
Advances in Clinical Chemistry
M Mahler
Advances in Clinical Chemistry Volume 54 2011
ABC transporters, atherosclerosis and inflammation
ML Fitzgerald, Z Mujawar, N Tamehiro
Atherosclerosis 2010
Emerging roles of the intestine in control of cholesterol metabolism
JK Kruit, AK Groen, TJ van Berkel, F Kuipers
World journal of gastroenterology : WJG 2006
Laboratory Techniques in Biochemistry and Molecular Biology
S Chen, KM Madsen, CC Tisher, A Agarwal
Laboratory Techniques in Biochemistry and Molecular Biology 2005
Postprandial hypertriglyceridaemia in patients with Tangier disease
G Kolovou, D Daskalova, K Anagnostopoulou, I Hoursalas, V Voudris, DP Mikhailidis, DV Cokkinos
Journal of clinical pathology 2003
Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease
BF Asztalos, ME Brousseau, JR McNamara, KV Horvath, PS Roheim, EJ Schaefer
Atherosclerosis 2001
Cholesterol efflux from normal and Tangier disease fibroblasts into normal, high-density lipoprotein-deficient, and apolipoprotein E-deficient plasmas
S Schuler-Lüttmann, Y Zhu, M Hoffmann, W März, G Feussner, H Wieland, G Assmann, A Eckardstein
Metabolism 2000
The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
M Bodzioch, E Orsó, J Klucken, T Langmann, A Böttcher, W Diederich, W Drobnik, S Barlage, C Büchler, M Porsch-Ozcürümez, WE Kaminski, HW Hahmann, K Oette, G Rothe, C Aslanidis, KJ Lackner, G Schmitz
Nature Genetics 1999
Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients
A Eckardstein, Y Huang, JJ Kastelein, J Geisel, JT Real, JA Kuivenhoven, R Miccoli, G Noseda, G Assmann
Atherosclerosis 1998
Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I
A von Eckardstein, A Chirazi, S Schuler-Lüttmann, M Walter, JJ Kastelein, J Geisel, JT Real, R Miccoli, G Noseda, G Höbbel, G Assmann
Journal of lipid research 1998
A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma
R Miccoli, Y Zhu, U Daum, J Wessling, Y Huang, R Navalesi, G Assmann, A von Eckardstein
Journal of lipid research 1997
Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms
M Walter, H Reinecke, U Gerdes, JR Nofer, G Höbbel, U Seedorf, G Assmann
Journal of Clinical Investigation 1996
Phospholipid transfer protein mediated conversion of high density lipoproteins generates preβ1-HDL
A Eckardstein, M Jauhiainen, Y Huang, J Metso, C Langer, P Pussinen, S Wu, C Ehnholm, G Assmann
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1996
Reverse Cholesterol Transport in Plasma of Patients With Different Forms of Familial HDL Deficiency
A von Eckardstein, Y Huang, S Wu, H Funke, G Noseda, G Assmann
Arteriosclerosis, thrombosis, and vascular biology 1995
Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux
MC Cheung, AJ Mendez, AC Wolf, RH Knopp
Journal of Clinical Investigation 1993
Tangier disease: isolation and characterization of LpA-I, LpA-II, LpA-I:A-II and LpA-IV particles from plasma
P Duchateau, D Rader, N Duverger, N Theret, CD Geitere, HB Brewer, JC Fruchart, GR Castro
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1993
Abnormal processing of Golgi elements and lysosomes in Tangier disease
H Robenek, G Schmitz
Arteriosclerosis Thrombosis and Vascular Biology 1991
Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol
H Hara, S Yokoyama
The Journal of biological chemistry 1991
Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia
P Alaupovic, C Knight-Gibson, CS Wang, D Downs, E Koren, HB Brewer, RE Gregg
Journal of lipid research 1991
Abnormalities in cholesterol metabolism cause peripheral neuropathy and dementia in AIDS—A hypothesis
A Falkenbach, S Klauke, PH Althoff
Medical Hypotheses 1990
Dysregulation of lipid metabolism in Tangier monocyte-derived macrophages
G Schmitz, H Fischer, M Beuck, KP Hoecker, H Robenek
Arteriosclerosis (Dallas, Tex.) 1990
Sequence and expression of Tangier apoA-I gene
SC MAKRIDES, N RUIZ-OPAZO, M HAYDEN, AL NUSSBAUM, JL BRESLOW, VI ZANNIS
European Journal of Biochemistry 1988
Eicosanoids, Apolipoproteins, Lipoprotein Particles, and Atherosclerosis
CL Malmendier, P Alaupovic
1988
Lipid Storage Disorders
R Salvayre, L Douste-Blazy, S Gatt
1988
High performance liquid chromatography and time-of-flight secondary ion mass spectrometry: a new dimension in structural analysis of apolipoproteins
HU Jabs, G Assmann, D Greifendorf, A Benninghoven
Journal of lipid research 1988
Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes
CS Wang, P Alaupovic, RE Gregg, HB Brewer
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1987
Enzyme-Linked Immunosorbent Assay for Apolipoprotein C-I
WR Riesen, E Sturzenegger
Clinical Chemistry and Laboratory Medicine 1986
Immunochemical study of the plasma low and high density lipoproteins in Tangier disease
MF Dumon, S Visvikis, T Manabe, M Clerc
FEBS Letters 1986
Plasma Apolipoproteins and Lipids in Normal Persons and Patients with Hypertension
SS Lee, YM Jhoo, DJ Oh, MH Lee, ES Chung, SJ Lee
The Korean Journal of Internal Medicine 1986
Interaction of Tangier lipoproteins with cholesteryl ester-laden mouse peritoneal macrophages
G Schmitz, G Assmann, B Brennhausen, HJ Schaefer
Journal of lipid research 1986
Nature of the enhancement of lecithin-cholesterol acyltransferase reaction by various apolipoproteins
HI Nishida, T Nakanishi, EA Yen, H Arai, FT Yen, T Nishida
The Journal of biological chemistry 1986
Relationship of the phenotypic expression of the A-IMilano apoprotein with plasma lipid and lipoprotein patterns
G Franceschini, CR Sirtori, E Bosisio, V Gualandri, GB Orsini, AM Mogavero, A Capurso
Atherosclerosis 1985
Turbidimetric Assay of Apolipoprotein A-II
H Schriewer, F Emke, G Assmann
Clinical Chemistry and Laboratory Medicine 1985
Tangier disease: a disorder of intracellular membrane traffic
G Schmitz, G Assmann, H Robenek, B Brennhausen
Proceedings of the National Academy of Sciences 1985
Automated immunoturbidimetric assay of serum apolipoprotein A-II using the COBAS-BIO™ centrifugal analyser: Influence of hyperlipoproteinemia
H Hachem, G Raynal, M Hamza, P Canal, G Soula
Clinical Biochemistry 1985
Tangier disease apolipoprotein A-I compared with normal plasma A-I using monoclonal antibodies
PK Weech, J Frohlich, YL Marcel, TD N'Guyen, RW Milne
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1985
Advances in Human Genetics 14
H Harris, K Hirschhorn
1985
Familial apolipoprotein A-I and C-III deficiency, variant II
EJ Schaefer, JM Ordovas, SW Law, G Ghiselli, ML Kashyap, LS Srivastava, WH Heaton, JJ Albers, WE Connor, FT Lindgren
Journal of lipid research 1985
Lipid-protein interaction at solid-water interface. Adsorption of human apo-high density lipoprotein to amphiphilic interfaces
BW Shen
The Journal of biological chemistry 1985
Bile lipid composition and haemostatic variables in a case of high density lipoprotein deficiency (Tangier disease)
CG Vergani, AC Plancher, M Zuin, M Cattaneo, C Tramaloni, S Maccari, P Roma, AL Catapano
European Journal of Clinical Investigation 1984
Black-white differences in plasma levels of apolipoproteins: The Evans County Heart Study
G Heiss, G Schonfeld, JL Johnson, S Heyden, CG Hames, HA Tyroler
American Heart Journal 1984
Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency
EJ Schaefer
Arteriosclerosis (Dallas, Tex.) 1984
Pathophysiology of Plasma Protein Metabolism
G Mariani
1984
Apolipoproteinopathien
G Assmann
Klinische Wochenschrift 1983
Competitive Enzyme Immunoassay for Apolipoprotein A-II
B Dufaux, K Ilsemann, G Assmann
Clinical Chemistry and Laboratory Medicine 1983
Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins
G Schmitz, G Assmann, SC Rall, RW Mahley
Proceedings of the National Academy of Sciences 1983
Massive omental reticuloendothelial cell lipid uptake in tangier disease after splenectomy
EJ Schaefer, TJ Triche, LA Zech, LA Stein, MM Kemeny, MF Brennan, HB Brewer
The American Journal of Medicine 1983
Fish eye disease: a new familial condition with massive corneal opacities and dyslipoproteinaemia Clinical and laboratory studies in two afflicted families
LA Carlson
European Journal of Clinical Investigation 1982
Hypolipidemia
MJ Malloy, JP Kane
Medical Clinics of North America 1982
Radioimmunoassay of apolipoprotein a-ii
TA Musliner, PA Garner, LO Henderson, PN Herbert
Arteriosclerosis (Dallas, Tex.) 1982
Tangier disease: Heterozygote detection and linkage analysis
BK Suarez, G Schonfeld, RS Sparkes
Human Genetics 1982
Abnormal apoprotein A-I isoprotein composition in patients with Tangier disease
VI Zannis, AM Lees, RS Lees, JL Breslow
The Journal of biological chemistry 1982
One-step screening method for the polymorphism of apolipoproteins A-I, A-II, and A-IV
HJ Menzel, RG Kladetzky, G Assmann
Journal of lipid research 1982
Characterization and quantitation of apolipoproteins A-I and E of normal and cholesterol-fed guinea pigs
LS Guo, RL Hamilton, JP Kane, CJ Fielding, GC Chen
Journal of lipid research 1982
Hepatic apo-A-I and apo-E and intestinal apo-A-I are synthesized in precursor isoprotein forms by organ cultures of human fetal tissues
VI Zannis, DM Kurnit, JL Breslow
The Journal of biological chemistry 1982
Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease)
P Alaupovic, EJ Schaefer, WJ McConathy, JD Fesmire, H Bryan^Brewer
Metabolism 1981
Metabolism of high density lipoprotein subfractions and constituents in Tangier disease following the infusion of high density lipoproteins
EJ Schaefer, DW Anderson, LA Zech, FT Lindgren, TB Bronzert, EA Rubalcaba, HB Brewer
Journal of lipid research 1981
A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family
G Franceschini, CR Sirtori, AC 2nd, KH Weisgraber, RW Mahley
Journal of Clinical Investigation 1980
A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins
KH Weisgraber, TP Bersot, RW Mahley, G Franceschini, CR Sirtori
Journal of Clinical Investigation 1980
Biochemie der High Density Lipoproteine
G Assmann, H Schriewer
Klinische Wochenschrift 1980
Plasma apolipoprotein profiles of male and female rats
BJ van Lenten, CH Jenkins, PS Roheim
Atherosclerosis 1980
Electroimmunoassay and Radioimmunoassay for the Quantitation of High Density Apolipoproteins A-I and A-II
RC Mordasini, WF Riesen
Clinical Chemistry and Laboratory Medicine 1980
The effect of D-thyroxine on lipoprotein lipids and apolipoproteins in primary type IIa hyperlipoproteinemia
P Schwandt, P Weisweiler
Atherosclerosis 1980
Plasma Lipids
H Malmros
Plasma Lipids 1980
Atherosclerosis V
AM Gotto, LC Smith, B Allen
1980
Isoproteins of human apolipoprotein A-I demonstrated in plasma and intestinal organ culture
VI Zannis, JL Breslow, AJ Katz
The Journal of biological chemistry 1980
Characterization and measurement of human apolipoprotein A-II by radioimmunoassay
RB Goldberg, JB Karlin, DJ Juhn, AM Scanu, C Edelstein, AH Rubenstein
Journal of lipid research 1980
Die Tangier Krankheit ? Klinik und Pathophysiologie
G Assmann
Klinische Wochenschrift 1979
Charge-shift electrophoresis of apolipoproteins from normal humans and patients with tangier disease
G Utermann, U Beisiegel
FEBS Letters 1979
Apolipoprotein C-II and C-III levels in hyperlipoproteinemia
G Schonfeld, PK George, J Miller, P Reilly, J Witztum
Metabolism 1979
Demonstration of human apolipoprotien A in isolated mucosal cells from small intestine and isolated hepatocytes
U Hopf, G Assmann, HE Schaefer, A Capurso
Gut 1979
Contemporary Metabolism
N Freinkel
1979
Plasma, apolipoprotein A-I and A-II levels in hyperlipidemia
G Schonfeld, A Bailey, R Steelman
Lipids 1978
Apoprotein a metabolism in tangier disease
G Assmann, A Capurso, E Smootz, U Wellner
Atherosclerosis 1978
Metabolism of apolipoproteins A-I and A-ll and its influence on the high density lipoprotein subfraction distribution in males and females
J Shepherd, CJ Packard, JR Patsch, AM Gotto, OD Taunton
European Journal of Clinical Investigation 1978
High density lipoprotein infusion and partial plasma exchange in Tangier disease
G Assmann, E Smootz
European Journal of Clinical Investigation 1978
Metabolism of apolipoprotein A-I in healthy young adults
MJ Caslake, E Farish, J Shepherd
Metabolism 1978
Quantitation of the major apoproteins of human high density lipoproteins by solid phase radioimmunoassay
WF Riesen, RC Mordasini, GW Middelhoff
FEBS Letters 1978
Metabolism of High-Density Lipoprotein Apolipoproteins in Tangier Disease
EJ Schaefer, CB Blum, RI Levy, LL Jenkins, P Alaupovic, DM Foster, HB Brewer
New England Journal of Medicine 1978
Apoprotein A-I Synthesis in Normal Intestinal Mucosa and in Tangier Disease
RM Glickman, PH Green, RS Lees, A Tall
New England Journal of Medicine 1978
The Role of High Density Lipoproteins in Lecithin: Cholesterol Acyltransferase Activity: Perspectives from Tangier Disease
G Assmann, G Schmitz, H Heckers
Scandinavian Journal of Clinical & Laboratory Investigation 1978
The Lipoprotein Molecule
H Peeters
1978
Aktuelle Probleme der Pathobiochemie
H Lang, W Rick, L Róka
1978
Lipoprotein apoprotein metabolism
EJ Schaefer, S Eisenberg, RI Levy
Journal of lipid research 1978
Isolation and Characterization of an Abnormal High Density Lipoprotein in Tangier Disease
G Assmann, PN Herbert, DS Fredrickson, T Forte
Journal of Clinical Investigation 1977
Characterization of high density lipoproteins in patients heterozygous for Tangier disease
G Assmann, O Simantke, HE Schaefer, E Smootz
Journal of Clinical Investigation 1977
Advances in Lipid Research
AM Scanu
Advances in Lipid Research 1965

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts